EDMOND DE ROTHSCHILD HOLDING S.A. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$8,241,000
+29.6%
154,1600.0%0.28%
+9.9%
Q3 2020$6,359,000
+8.7%
154,160
+27.8%
0.25%
+4.6%
Q2 2020$5,848,000
+14.7%
120,6600.0%0.24%
-9.7%
Q1 2020$5,098,000
+65.3%
120,660
+67.4%
0.27%
+118.9%
Q4 2019$3,084,000
-19.2%
72,100
-32.0%
0.12%
-20.3%
Q3 2019$3,815,000
-52.5%
106,000
-64.7%
0.15%
-49.3%
Q2 2019$8,027,000
-21.7%
300,300
-21.4%
0.30%
-14.9%
Q1 2019$10,257,000
+54.0%
382,000
-7.3%
0.36%
+51.7%
Q4 2018$6,662,000
-21.7%
412,000
+0.5%
0.23%
-3.3%
Q3 2018$8,512,000
+50.9%
410,000
+11.0%
0.24%
+50.3%
Q2 2018$5,641,000
-26.2%
369,452
+8.7%
0.16%
-27.5%
Q1 2018$7,640,000
-25.4%
340,0000.0%0.22%
-24.5%
Q4 2017$10,237,000
-41.6%
340,000
-26.9%
0.29%
-41.1%
Q3 2017$17,517,000
+32.2%
465,000
-2.1%
0.50%
+33.8%
Q2 2017$13,248,000
+21.8%
475,000
+50.1%
0.37%
+29.5%
Q1 2017$10,877,000
+277.1%
316,380
+216.4%
0.29%
+260.0%
Q4 2016$2,884,000100,0000.08%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
March Altus Capital Management LP 82,723$2,685,00020.75%
HWG Holdings LP 289,380$9,393,0008.72%
Baker Brothers Advisors 24,516,738$795,813,0008.34%
HARVEY CAPITAL MANAGEMENT INC 352,200$11,432,0005.73%
Belmont Global Advisors, Inc. 150,000$4,869,0004.67%
Palo Alto Investors LP 1,437,730$46,669,0003.52%
Avoro Capital Advisors LLC 329,500$10,696,0002.38%
GARRISON BRADFORD & ASSOCIATES INC 70,100$2,275,0002.23%
WEATHERBIE CAPITAL, LLC 401,642$13,037,0001.85%
ACUTA CAPITAL PARTNERS, LLC 85,999$2,792,0001.34%
View complete list of ACADIA PHARMACEUTICALS INC shareholders